The human paraoxonase Gln-Argl92 (Q/R) polymorphism in turkish patients with coronary artery disease.

It has been suggested that a Q/R (Glnl92Arg) polymorphism of paraoxonase (PON) might be associated with the predisposition to coronary artery disease (CAD). Therefore, we studied the human paraoxonase gene (PON1) polymorphism in Turkish patients with CAD by polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP). This polymorphism was determined in 96 CAD patients and in 105 control subjects. The frequencies of the QQ, QR, and RR genotypes were found as 36.5, 52.0, and 11.5% in CAD patients and 48.6, 41.0, and 10.4% in control subjects, respectively. The QR genotype was the most common in the patient group, whereas the QQ genotype was more frequent in individuals without CAD. Frequency of the R allele was higher among CAD patients compared to controls (38.5% versus 31%). However, neither the genotype nor the allele distribution of the Gln92Arg polymorphism of PON1 was statistically significantly different between the two groups (P>0.05). Although both systolic and diastolic blood pressure levels were slightly higher in patients with the QQ genotype, there was no differences in regard to age, sex, serum triglyceride, total cholesterol or high-density lipoprotein cholesterol among CAD patients with different PONI Gln192Arg genotypes. In summary, our results suggest that no association exists between the Gln192Arg polymorphism of paraoxonase and CAD in Turkish patients.